Publications by authors named "Ana Clara Martins Silva Carvalho"
Article Synopsis
- The study aimed to assess the impact of chromium supplementation on glucose levels and body measurements in type 2 diabetic patients.
- 56 participants were divided into three groups (placebo, 50μg, and 200μg of chromium), with evaluations done at the start, 45 days, and 90 days.
- Results indicated no significant differences in glucose regulation or body composition among groups, although some changes were noted in specific measurements.
- Ultimately, chromium supplementation did not lead to any improvements in glucose homeostasis or physical stats after 90 days.
Objective: To investigate the effect of chromium nicotinate supplementation on insulin sensitivity, glycemic control, and lipid profile in subjects with type 2 diabetes.
Materials And Methods: In a double-blind clinical trial, 56 overweight individuals with type 2 diabetes were randomized into 3 groups: placebo (NC0), 50 μg (NC50), and 200 μg (NC200) of chromium as chromium nicotinate. Chromium status, sensitivity to insulin, glycemic control, and lipid profile were assessed at the beginning of the study and 45 days and 90 days after.